Located in Pomezia, IMS produces disinfectant chemistries used in automated endoscope reprocessors (AERs), as well as other infection prevention and control chemistries used in healthcare and dental markets.

The acquired business will be included in the Medivators business unit, and will report as part of the endoscopy segment, said Cantel Medical.

Cantel Medical COO and Medivators president Jorgen Hansen said: "The addition of IMS to our Medivators Endoscopy segment compliments this business with the most competitive global AER portfolio and adds key global R&D and manufacturing capabilities to our organization.

"We look forward to manufacturing both IMS’ line of chemistries as well as Medivators’ range of infection prevention chemistries at the IMS facility for sale throughout the European continent."

Cantel Medical produces products, including medical device reprocessing systems for endoscopy and renal dialysis and water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, as well as disposable infection control products for dental and GI endoscopy markets.